2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

被引：29

作者：

Herrstedt, J. ^{[1
,2
]}

Clark-Snow, R. ^{[3
]}

Ruhlmann, C. H. ^{[4
,5
]}

Molassiotis, A. ^{[6
]}

Olver, I. ^{[7
]}

Rapoport, B. L. ^{[8
,9
]}

Aapro, M. ^{[10
]}

Dennis, K. ^{[11
,12
]}

Hesketh, P. J. ^{[13
]}

Navari, R. M. ^{[14
]}

Schwartzberg, L. ^{[15
]}

Affronti, M. L. ^{[16
,17
]}

Garcia-Del-Barrio, M. A. ^{[18
,19
]}

Chan, A. ^{[20
]}

Celio, L.

Chow, R. ^{[21
]}

Fleury, M. ^{[22
]}

Gralla, R. J. ^{[23
]}

Giusti, R. ^{[24
]}

Jahn, F. ^{[25
]}

Iihara, H. ^{[26
]}

Maranzano, E. ^{[27
]}

Radhakrishnan, V. ^{[28
]}

Saito, M. ^{[29
]}

Sayegh, P. ^{[30
]}

Bosnjak, S. ^{[31
]}

Zhang, L. ^{[32
]}

Lee, J. ^{[33
,34
]}

Ostwal, V. ^{[35
]}

Smit, T. ^{[8
]}

Zilic, A. ^{[31
]}

Jordan, K. ^{[36
,37
]}

Scotte, F. ^{[38
]}

机构：

[1] Zealand Univ Hosp Roskilde & Naestved, Dept Clin Oncol, Roskilde, Denmark

[2] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark

[3] Oncol Support Care Consultant, Overland Pk, KS USA

[4] Odense Univ Hosp, Dept Oncol, Odense, Denmark

[5] Univ Southern Denmark, Dept Clin Res, Odense, Denmark

[6] Univ Derby, Coll Arts Humanities & Educ, Derby, England

[7] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia

[8] Med Oncol Ctr Rosebank, Johannesburg, South Africa

[9] Univ Pretoria, Fac Hlth Sci, Dept Immunol, Pretoria, South Africa

[10] Genolier Canc Ctr, Genolier, Switzerland

[11] Ottawa Hosp, Div Radiat Oncol, Ottawa, ON, Canada

[12] Univ Ottawa, Ottawa, ON, Canada

[13] Lahey Hosp & Med Ctr, Div Hematol Oncol, Burlington, MA USA

[14] WHO, Birmingham, England

[15] Univ Nevada, William N Pennington Canc Inst, Reno Sch Med, Reno, NV USA

[16] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Dept Neurosurg, Med Ctr, Durham, NC USA

[17] Duke Univ, Sch Nursing, Durham, NC USA

[18] Clin Univ Navarra, Pharm Dept, Madrid, Spain

[19] Univ Navarra, Sch Pharm & Nutr, Pamplona, Spain

[20] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm Practice, Irvine, CA USA

[21] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada

[22] Univ Lausanne, Fac Biol & Med, Dept Oncol, Lausanne, Switzerland

[23] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY USA

[24] St Andrea Hosp Rome, Med Oncol Unit, Rome, Italy

[25] Univ Hosp Halle Saale, Clin Internal Med Oncol Hematol Hemostaseol 4, Halle, Germany

[26] Gifu Univ Hosp, Dept Pharm, Gifu, Japan

[27] Univ Perugia, Perugia, Italy

[28] Canc Inst WIA, Dept Med Oncol, Chennai, India

[29] Juntendo Univ, Dept Breast Oncol, Sch Med, Tokyo, Japan

[30] OU Hlth Stephenson Canc Ctr, Dept Pharm, Oklahoma City, OK USA

[31] Inst Oncol & Radiol Serbia, Dept Support Oncol & Palliat Care, Belgrade, Serbia

[32] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China

[33] Yonsei Univ, Coll Nursing, Seoul, South Korea

[34] Yonsei Univ, Mo Im Kim Nursing Res Inst, Seoul, South Korea

[35] Homi Bhabha Natl Inst, Tata Mem Hosp, Dept Med Oncol, Mumbai, Maharashtra, India

[36] Ernst Von Bergmann Hosp, Dept Hematol Oncol & Palliat Med, Potsdam, Germany

[37] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany

[38] Gustave Roussy, Interdisciplinary Patient Pathway Div, Villejuif, France

来源：

ESMO OPEN | 2024年 / 9卷 / 02期

关键词：

prevention; nausea and vomiting; MASCC- ESMO Clinical Practice Guideline; radiotherapy; chemotherapy; COMBINATION ANTIEMETIC THERAPY; OXALIPLATIN-BASED CHEMOTHERAPY; RADIATION-INDUCED NAUSEA; RANDOMIZED PHASE-III; DOUBLE-BLIND; RECEPTOR ANTAGONIST; RECEIVING CHEMOTHERAPY; 3-DAY DEXAMETHASONE; SENRI TRIAL; CANCER;

D O I：

10.1016/j.esmoop.2023.102195

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页数：18

共 99 条

[1] Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT)
Ades, Steven
Halyard, M.
Wilson, K.
Ashikaga, T.
Heimann, R.
Kumar, S.
Blackstock, W.
[J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1503 - 1510
[2] Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study
Albany, Costantine
Brames, Mary J.
Fausel, Christopher
Johnson, Cynthia S.
Picus, Joel
Einhorn, Lawrence H.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3998 - 4003
[3] Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large-scale administrative database
Bun, Seiko
Kunisawa, Susumu
Sasaki, Noriko
Fushimi, Kiyohide
Matsumoto, Kimikazu
Yamatani, Akimasa
Imanaka, Yuichi
[J]. CANCER MEDICINE, 2019, 8 (14): : 6243 - 6249
[4] Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
Cao, Jun
Ouyang, Quchang
Wang, Shusen
Ragaz, Joseph
Wang, Xiaojia
Teng, Yuee
Wang, Biyun
Wang, Zhonghua
Zhang, Jian
Wang, Leiping
Wu, Jiong
Shao, Zhimin
Hu, Xichun
[J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 507 - 514
[5] Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital
Caracuel, Fatima
Munoz, Nuria
Banos, Ursula
Ramirez, Gabriel
[J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (03) : 163 - 169
[6] Infusion reactions following administration of intravenous rolapitant at an academic medical center
Cass, Amanda S.
Odinet, Johlee S.
Valgus, John M.
Crona, Daniel J.
[J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1776 - 1783
[7] Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
Celio, Luigi
Cortinovis, Diego
Cogoni, Alessio Aligi
Cavanna, Luigi
Martelli, Olga
Carnio, Simona
Collova, Elena
Bertolini, Federica
Petrelli, Fausto
Cassano, Alessandra
Chiari, Rita
Zanelli, Francesca
Pisconti, Salvatore
Vittimberga, Isabella
Letizia, Antonietta
Misino, Andrea
Gernone, Angela
Bonizzoni, Erminio
Pilotto, Sara
De Placido, Sabino
Bria, Emilio
[J]. ONCOLOGIST, 2021, 26 (10) : E1854 - E1861
[8] Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
Celio, Luigi
Bonizzoni, Erminio
Zattarin, Emma
Codega, Paolo
de Braud, Filippo
Aapro, Matti
[J]. BMC CANCER, 2019, 19 (01)
[9] Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study
Celio, Luigi
Saibene, Gabriella
Lepori, Stefano
Festinese, Fabrizio
Niger, Monica
Raspagliesi, Francesco
Lorusso, Domenica
[J]. TUMORI JOURNAL, 2019, 105 (03): : 253 - 258
[10] Efficacy of Auricular Acupressure in Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review and Meta-Analysis
Chen, Lichan
Wu, Xiaohong
Chen, Xisui
Zhou, Chunjiao
[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021

← 1 2 3 4 5 6 7 8 9 10 →